Anika Therapeutics, Inc. (ANIK) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $134.00K; Additional Paid in Capital, Common StockUSD $83.44M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.33M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $133.00K; Additional Paid in Capital, Common StockUSD $83.35M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.31M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $139.00K; Additional Paid in Capital, Common StockUSD $87.50M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.96M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $144.00K; Additional Paid in Capital, Common StockUSD $91.11M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.94M.
Anika Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $134.00K | $83.44M | $-5.33M | $59.04M | $137.28M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $133.00K | $83.35M | $-5.31M | $55.73M | $133.90M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $139.00K | $87.50M | $-4.96M | $60.79M | $143.47M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $144.00K | $91.11M | $-4.94M | $60.49M | $146.81M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $144.00K | $89.46M | $-4.75M | $62.82M | $147.67M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $143.00K | $87.56M | $-6.10M | $66.79M | $148.40M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $144.00K | $88.96M | $-6.78M | $71.67M | $153.99M | 12 month · $11.68M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $147.00K | $91.89M | $-5.70M | $93.53M | $179.86M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $148.00K | $93.16M | $-6.42M | $123.45M | $210.34M | 3 month · $3.10M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $148.00K | $91.17M | $-6.32M | $123.54M | $208.54M | 3 month · $3.43M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $147.00K | $90.01M | $-5.94M | $128.05M | $212.26M | 12 month · $15.24M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $146.00K | $85.85M | $-6.56M | $191.05M | $270.49M | 3 month · $3.56M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $147.00K | $82.40M | $-6.16M | $197.63M | $274.01M | 3 month · $4.15M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $147.00K | $83.24M | $-6.17M | $200.37M | $277.59M | 3 month · $3.72M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $146.00K | $81.14M | $-6.44M | $210.72M | $285.56M | 12 month · $14.31M | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $146.00K | $76.66M | $-7.50M | $215.63M | $284.94M | 3 month · $3.88M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $146.00K | $72.85M | $-6.65M | $219.80M | $286.15M | 3 month · $4.08M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $145.00K | $68.80M | $-5.80M | $222.65M | $285.79M | 3 month · $2.54M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $144.00K | $67.08M | $-5.72M | $225.58M | $287.08M | 12 month · $11.09M | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $144.00K | $63.86M | $-5.32M | $231.37M | $290.06M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $144.00K | $60.70M | $-4.85M | $230.81M | $286.80M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $144.00K | $57.28M | $-5.05M | $224.28M | $276.66M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $143.00K | $55.35M | $-4.54M | $221.44M | $272.40M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $142.00K | $52.51M | $-5.30M | $237.10M | $284.45M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $142.00K | $50.61M | $-5.82M | $243.51M | $288.44M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $142.00K | $48.36M | $-6.03M | $251.22M | $293.69M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $143.00K | $48.71M | $-5.90M | $245.43M | $288.38M | 12 month · $6.09M | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $143.00K | $46.48M | $-6.32M | $241.38M | $281.68M | 3 month · $1.31M | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $138.00K | $24.33M | $-5.70M | $232.18M | $250.95M | 3 month · $1.44M | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $142.00K | $52.03M | $-5.84M | $222.74M | $269.07M | 3 month · $1.39M | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $142.00K | $50.76M | $-5.53M | $218.23M | $263.61M | 12 month · $11.05M | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $142.00K | $49.84M | $-5.23M | $210.51M | $255.26M | 3 month · $1.18M | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $146.00K | $48.66M | $-5.12M | $202.92M | $246.60M | 3 month · $1.32M | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $147.00K | $74.96M | $-4.16M | $192.82M | $263.77M | 3 month · $7.57M | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $147.00K | $68.62M | $-4.78M | $199.51M | $263.49M | 12 month · $5.81M | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $146.00K | $66.75M | $-5.05M | $191.44M | $253.29M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $146.00K | $65.17M | $-5.74M | $184.56M | $244.14M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $146.00K | $63.72M | $-7.03M | $173.19M | $230.03M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $146.00K | $61.73M | $-7.32M | $168.21M | $222.77M | 12 month · $3.39M | (m) | (m) | 12 month · $647.00K |
| 2016-09-30 | (m) | $146.00K | $60.37M | $-6.10M | $160.12M | $214.54M | (m) | (m) | (m) | 3 month · $0.00 9 month · $400.00K |
| 2016-06-30 | (m) | $148.00K | $59.51M | $-6.41M | $151.17M | $204.42M | (m) | (m) | (m) | 3 month · $100.00K 6 month · $400.00K |
| 2016-03-31 | (m) | $148.00K | $58.54M | $-5.87M | $142.56M | $195.37M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $150.00K | $81.69M | $-6.65M | $135.66M | $210.85M | 12 month · $2.23M | (m) | (m) | 12 month · $847.00K |
| 2015-09-30 | $0.00 | $150.12K | $81.05M | (m) | $124.62M | $199.75M | (m) | (m) | $-6.07M | (m) |
| 2015-06-30 | $0.00 | $150.04K | $80.51M | (m) | $116.24M | $190.57M | (m) | (m) | $-6.33M | (m) |
| 2015-03-31 | $0.00 | $150.03K | $79.99M | (m) | $108.42M | $181.82M | (m) | (m) | $-6.74M | (m) |
| 2014-12-31 | $0.00 | $149.00K | $77.54M | $-4.50M | $104.90M | $178.10M | 12 month · $1.61M | (m) | $-4.49M | 12 month · $9.63M |
| 2014-09-30 | (m) | $148.00K | $76.06M | (m) | $97.09M | $169.70M | (m) | (m) | $-3.60M | (m) |
| 2014-06-30 | (m) | $147.98K | $73.25M | (m) | $90.92M | $162.39M | (m) | (m) | $-1.92M | (m) |
| 2014-03-31 | (m) | $146.20K | $76.53M | (m) | $81.61M | $156.57M | (m) | (m) | $-1.73M | (m) |
| 2013-12-31 | $0.00 | $142.89K | $70.61M | (m) | $66.58M | $135.63M | 12 month · $1.27M | (m) | $-1.70M | 12 month · $857.00K |
| 2013-09-30 | (m) | $142.66K | $70.28M | (m) | $59.93M | $128.21M | (m) | (m) | $-2.15M | (m) |
| 2013-06-30 | (m) | $140.17K | (m) | (m) | $54.97M | $119.43M | (m) | $67.39M | $-3.06M | (m) |
| 2013-03-31 | (m) | $140.06K | (m) | (m) | $49.08M | $112.83M | (m) | $67.01M | $-3.40M | (m) |
| 2012-12-31 | (m) | $138.66K | $65.43M | (m) | $46.01M | $108.92M | 12 month · $1.15M | $65.43M | $-2.65M | 12 month · $452.47K |
| 2012-09-30 | (m) | $138.05K | (m) | (m) | $41.55M | $103.47M | (m) | $65.14M | $-3.35M | (m) |
| 2012-06-30 | (m) | $137.66K | (m) | (m) | $39.90M | $100.75M | (m) | $64.62M | $-3.91M | (m) |
| 2012-03-31 | (m) | $137.63K | (m) | (m) | $36.16M | $98.26M | (m) | $64.27M | $-2.31M | (m) |
| 2011-12-31 | (m) | $136.31K | (m) | (m) | $34.25M | $94.76M | 12 month · $1.19M | $63.44M | $-3.07M | 12 month · $274.19K |
| 2011-09-30 | (m) | $136.22K | (m) | (m) | $31.37M | $92.85M | (m) | $63.13M | $-1.78M | (m) |
| 2011-06-30 | (m) | $136.22K | (m) | (m) | $28.39M | $91.13M | (m) | $62.81M | $-202.91K | (m) |
| 2010-12-31 | (m) | $134.82K | (m) | (m) | $25.79M | $85.19M | 12 month · $1.10M | $61.82M | $-2.55M | 12 month · $-21.19K |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $82.14M | 12 month · $958.02K | (m) | (m) | 12 month · $-82.54K |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $60.76M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |